Although the relationship between microbiota changes and PRL activity has been scarcely explored, variations in PRL levels are linked to metabolic changes, potentially implicating microbiota dysbiosis, and this is one of the mechanisms involved in the development of cardiovascular diseases, obesity, and type 2 diabetes [15]. The gene discussed is PRL; the disease is obesity due to melanocortin 4 receptor deficiency.